Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01424306 · ClinicalTrials.gov registry record · NA
Diet and Systemic Inflammation
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01424306 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 25 participants.
The verdict
NCT01424306, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
People with chronic low-grade inflammation have a higher risk for certain diseases such as cardiovascular disease or type 2 diabetes. While it is known that obese people are more likely to show signs of low-grade inflammation than lean individuals, it is unclear what causes this inflammation. In the proposed study, the investigators will examine whether the sugar fructose, when consumed in a sweetened beverage, triggers low-grade inflammation in healthy men and women compared with other caloric sweeteners.
Interventions
- OTHER Fructose-sweetened beverages
- OTHER Glucose-sweetened beverages
- OTHER High-fructose corn syrup-sweetened beverages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01424306
The ClinicalTrials.gov registry entry for NCT01424306 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fructose-sweetened beverages is the first listed.
NCT01424306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01424306 about?
NCT01424306 is a clinical study titled "Diet and Systemic Inflammation". People with chronic low-grade inflammation have a higher risk for certain diseases such as cardiovascular disease or type 2 diabetes. While it is known that obese people are more likely to show signs of low-grade inflammation than lean individuals, it is unclear what causes this inflammation. In the...
What is the current status of trial NCT01424306?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2011-10. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01424306?
The interventions under investigation include: Fructose-sweetened beverages (OTHER), Glucose-sweetened beverages (OTHER), High-fructose corn syrup-sweetened beverages (OTHER).
Who is sponsoring clinical trial NCT01424306?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.